Evidence map›Paper›PMID 34532099›Full record

ArticleJournal of gastrointestinal oncology2021

Neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib and S-1 chemotherapy for conversion therapy in gastric cancer patients with positive exfoliative cytology: a prospective study.

Ping'an Ding, Peigang Yang, Yuan Tian, Honghai Guo, Yang Liu, Ze Zhang, Tao Zheng, Bibo Tan, Zhidong Zhang, Dong Wang and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of gastrointestinal oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Catheter based intraperitoneal chemotherapy using taxane for peritoneal metastases from gastric cancer: from bench to bedside-a narrative review.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ping'an DingThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Peigang YangThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yuan TianThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Honghai GuoThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yang LiuThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Ze ZhangThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Tao ZhengThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Bibo TanThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Zhidong ZhangThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Dong WangThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Yong LiThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Qun ZhaoThe Third Department of Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Fourth Hospital of Hebei Medical University · CNHebei Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo explore the efficacy and safety of neoadjuvant intraperitoneal and systemic (NIPS) paclitaxel chemotherapy combined with apatinib and S-1 in the treatment of gastric cancer patients with positive exfoliative cytology.

methodsPatients with gastric cancer (P

resultsOut of 312 advanced gastric cancer patients who underwent laparoscopic exploration, 36 patients with P

conclusionsNIPS with paclitaxel combined with apatinib and S-1 treatment may increase the FCC negative rate of P

Indexed as

abdominal exfoliation cytology positiveApatinibgastric cancerneoadjuvant intraperitoneal and systemic treatment (NIPS treatment)

Identifiers

PMID34532099
PMCPMC8421905
OpenAlexW3196265559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.